Vaccine
💉 New vaccine reduced Lyme disease cases by 70 percent in clinical trial
Pharmaceutical companies Pfizer and Valneva report that their Lyme disease vaccine LB6V reduced the number of disease cases by around 70 percent compared with placebo. It would become the first approved Lyme disease vaccine for humans in nearly three decades.
🧬 From 13% to 88%: This many survive pancreatic cancer thanks to new vaccine
Pancreatic cancer is one of the deadliest cancers. Fewer than 13 percent of those diagnosed survive more than five years. But after receiving a new mRNA vaccine, nearly 90 percent are still alive six years later.
🪱 Hookworm vaccine reduces infection in trial – could help millions with anemia
Hookworm infects more than 100 million people and is a major cause of iron-deficiency anemia, particularly in children and pregnant women. A phase 2 trial shows that a vaccine candidate substantially reduces the intensity of infection.
🧒 First vaccine that protects children from deadly E. coli infections
ETVAX is the first vaccine to show significant protection against E. coli infections in humans. The vaccine reduced moderate-to-severe diarrhea in infants under nine months by 68 percent. A phase 3 trial with 5,800 infants from low- and middle-income countries is about to begin.
🤧 A single nasal spray vaccine could protect against all coughs, colds and flus
Researchers have developed a "universal vaccine" in the form of a nasal spray that in animal experiments protected against virtually all tested viruses, bacteria and even allergens. The method puts immune cells in the lungs in a heightened state of readiness.
📉 Measles deaths down 88 percent since 2000
The measles vaccine has saved nearly 59 million lives since the turn of the millennium. The number of deaths in 2024 is among the lowest recorded since 2000. 96 countries have now eliminated measles, including the first three countries in Africa.
💉 DR Congo launches vaccination campaign for 62 million children
DR Congo is launching a nationwide vaccination campaign against measles and rubella that will reach 62 million children aged 6 months to 14 years. The combined vaccine replaces the previous measles vaccine in the national immunization program.
💉 New vaccine can stop meningitis in Africa
A five-in-one vaccine has begun to be used in several African countries to protect against bacterial meningitis. The vaccine costs only three dollars per dose and protects against four types of bacteria that cause almost all meningitis epidemics in the region.
💉 Gavi's vaccines saved 1.7 million lives in 2024
Over 1.2 billion unique children have been vaccinated against a range of deadly diseases through routine vaccination since 2000.